MilliporeSigma to make Elypta liquid biopsy kits

By The Science Advisory Board staff writers

February 18, 2020 -- MilliporeSigma has signed an agreement with Swedish molecular diagnostics company Elypta to be the contract manufacturer for Elypta's clinical diagnostic liquid biopsy kits.

Elypta's liquid biopsy kits analyze metabolites that are deregulated in several types of cancer, resulting in more accurate diagnoses, according to MilliporeSigma. The kits to be manufactured will use a biofluid sample to detect and analyze biological markers for cancer, enabling clinicians to diagnose patients and determine treatment options.

The kits will be made at MilliporeSigma's manufacturing plant in St. Louis and initially will be for research use only with mass spectrometry systems. The kits will allow researchers to measure the full spectrum of human glycosaminoglycans in samples of body fluid.

The contract manufacturing agreement with MilliporeSigma will allow Elypta to commercialize its test without a major investment in manufacturing and will get the product to market sooner. The firm expects to have research-use-only kits on the market in 2020.

Elypta plans to qualify the kits for use with in vitro diagnostic applications in the U.S. and the European Union after completing clinical validation studies; one study will evaluate the test for the surveillance of kidney cancer recurrence.

MilliporeSigma unveils BrightLab for research scientists
MilliporeSigma has introduced BrightLab, a cloud-based inventory management and instrument connectivity platform for research scientists.
ReForm Biologics, MilliporeSigma ink license agreement
ReForm Biologics and MilliporeSigma have signed a licensing agreement to develop and market excipients used for biotherapeutic applications. The agreement...
MilliporeSigma licenses CRISPR tech to Promega
MilliporeSigma announced on December 19 that it has signed a license agreement providing Promega Corp., access to MilliporeSigma's foundational CRISPR...

Copyright © 2020 scienceboard.net


Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Email
Conferences
BioProcess International Europe
April 28 - May 1
Amsterdam, Noord-Holland Netherlands
Lab of the Future USA
May 19-20
Boston, Massachusetts United States
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
BioProcess International
September 21-24
Boston, Massachusetts United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter